Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
This report elaborates on the current development of the Insulin Glargine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Sanofi-Aventis
Biocon
Ganlee
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Single Dose Vial
Pre-filled Syringe
Application:
Treat type2 diabetes
Treat type1 diabetes
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Insulin Glargine Industry Overview
-
1.1.1 Insulin Glargine Market Scope and Market Segments
-
1.1.2 Insulin Glargine Industry Characteristics
-
1.1.3 Global and China Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Insulin Glargine Production Value and Growth Rate (2017-2028)
-
1.2 Global Insulin Glargine Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Single Dose Vial
-
1.2.2 Pre-filled Syringe
-
1.3 Global Insulin Glargine Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Treat type2 diabetes
-
1.3.2 Treat type1 diabetes
-
1.4 Market Analysis by Region
-
1.4.1 North America Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Insulin Glargine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Insulin Glargine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Insulin Glargine Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Insulin Glargine Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Insulin Glargine Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Insulin Glargine Industry Porter's Five Forces Model Analysis
-
2.2.3 Insulin Glargine Industry PEST Analysis
-
2.3 Insulin Glargine Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Insulin Glargine Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Insulin Glargine Industry
Chapter 3 Global and China Insulin Glargine Market, by Manufacturer
-
3.1 Global and China Insulin Glargine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Insulin Glargine Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Insulin Glargine Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Insulin Glargine Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Insulin Glargine Market Top 3 Players
Chapter 4 Global and China Insulin Glargine Market, by Type (2017-2028)
-
4.1 Insulin Glargine Market Trend, by Type
-
4.2 Global Insulin Glargine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Insulin Glargine Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Insulin Glargine Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Insulin Glargine Price Trend, by Type (2017-2028)
-
4.3 China Insulin Glargine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Insulin Glargine Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Insulin Glargine Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Insulin Glargine Price Trend, by Type (2017-2028)
Chapter 5 Global and China Insulin Glargine Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Insulin Glargine Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Insulin Glargine Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Insulin Glargine Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Insulin Glargine Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Insulin Glargine Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Insulin Glargine Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Insulin Glargine Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Insulin Glargine Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Insulin Glargine Market Analysis
-
7.1 North America Insulin Glargine Market, by Type
-
7.2 North America Insulin Glargine Market, by Application
-
7.3 North America Insulin Glargine Market Analysis and Forecast, by Country
-
7.3.1 United States Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Insulin Glargine Market Analysis
-
8.1 Europe Insulin Glargine Market, by Type
-
8.2 Europe Insulin Glargine Market, by Application
-
8.3 Europe Insulin Glargine Market Analysis and Forecast, by Country
-
8.3.1 Germany Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Insulin Glargine Market Analysis
-
9.1 APAC Insulin Glargine Market, by Type
-
9.2 APAC Insulin Glargine Market, by Application
-
9.3 APAC Insulin Glargine Market Analysis and Forecast, by Country
-
9.3.1 China Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Insulin Glargine Market Analysis
-
10.1 Latin America, Middle East and Africa Insulin Glargine Market, by Type
-
10.2 Latin America, Middle East and Africa Insulin Glargine Market, by Application
-
10.3 Latin America, Middle East and Africa Insulin Glargine Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Insulin Glargine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Insulin Glargine Company Profiles
-
11.1 Sanofi-Aventis
-
11.1.1 Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Sanofi-Aventis Insulin Glargine Product Profiles, Application and Specification
-
11.1.3 Sanofi-Aventis Insulin Glargine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Biocon
-
11.2.1 Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Biocon Insulin Glargine Product Profiles, Application and Specification
-
11.2.3 Biocon Insulin Glargine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Ganlee
-
11.3.1 Ganlee Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Ganlee Insulin Glargine Product Profiles, Application and Specification
-
11.3.3 Ganlee Insulin Glargine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Insulin Glargine Industry Investment Prospect and Risk Assessment
-
12.1 Insulin Glargine Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Insulin Glargine Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure China Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Global Insulin Glargine Production Value and Growth Rate (2017-2028)
-
Figure China Insulin Glargine Production Value and Growth Rate (2017-2028)
-
Figure Global Insulin Glargine Market Size and Growth Rate of Single Dose Vial (2017-2028)
-
Figure Global Insulin Glargine Market Size and Growth Rate of Pre-filled Syringe (2017-2028)
-
Figure Global Insulin Glargine Market Size and Growth Rate of Treat type2 diabetes (2017-2028)
-
Figure Global Insulin Glargine Market Size and Growth Rate of Treat type1 diabetes (2017-2028)
-
Figure North America Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Insulin Glargine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Insulin Glargine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Insulin Glargine Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Insulin Glargine Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Insulin Glargine Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Insulin Glargine Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Insulin Glargine Market Share, by Manufacturer in 2021
-
Figure Global and China Insulin Glargine Market Share, by Manufacturer in 2022
-
Table Global Insulin Glargine Sales Volume, by Type (2017-2028)
-
Table Global Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Figure Global Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Table Global Insulin Glargine Sales Value, by Type (2017-2028)
-
Table Global Insulin Glargine Sales Value Share, by Type (2017-2028)
-
Figure Global Insulin Glargine Price Trend, by Type (2017-2028)
-
Table China Insulin Glargine Sales Volume, by Type (2017-2028)
-
Table China Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Figure China Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Table China Insulin Glargine Sales Value, by Type (2017-2028)
-
Table China Insulin Glargine Sales Value Share, by Type (2017-2028)
-
Figure China Insulin Glargine Price Trend, by Type (2017-2028)
-
Table Global Insulin Glargine Sales Volume, by Application (2017-2028)
-
Table Global Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure Global Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Table Global Insulin Glargine Sales Value, by Application (2017-2028)
-
Table Global Insulin Glargine Sales Value Share, by Application (2017-2028)
-
Figure Global Insulin Glargine Sales Value Share, by Application (2017-2028)
-
Table China Insulin Glargine Sales Volume, by Application (2017-2028)
-
Table China Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure China Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Table China Insulin Glargine Sales Value, by Application (2017-2028)
-
Table China Insulin Glargine Sales Value Share, by Application (2017-2028)
-
Figure China Insulin Glargine Sales Value Share, by Application (2017-2028)
-
Figure China Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
Figure North America Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Insulin Glargine Production, Import, Consumption and Export (2017-2022)
-
Table North America Insulin Glargine Sales Volume, by Type (2017-2028)
-
Table North America Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Figure North America Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Table North America Insulin Glargine Sales Volume, by Application (2017-2028)
-
Table North America Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure North America Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure United States Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure United States Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Canada Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Table Europe Insulin Glargine Sales Volume, by Type (2017-2028)
-
Table Europe Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Figure Europe Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Table Europe Insulin Glargine Sales Volume, by Application (2017-2028)
-
Table Europe Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure Europe Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure Germany Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure UK Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure UK Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure France Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure France Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Italy Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Spain Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Poland Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Russia Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Table APAC Insulin Glargine Sales Volume, by Type (2017-2028)
-
Table APAC Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Figure APAC Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Table APAC Insulin Glargine Sales Volume, by Application (2017-2028)
-
Table APAC Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure APAC Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure China Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure China Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Japan Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure India Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure India Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Insulin Glargine Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Insulin Glargine Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Insulin Glargine Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Insulin Glargine Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Insulin Glargine Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Insulin Glargine Sales Value and Growth Rate (2017-2028)
-
Table Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi-Aventis Product Profiles, Application and Specification
-
Table Sanofi-Aventis Insulin Glargine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biocon Product Profiles, Application and Specification
-
Table Biocon Insulin Glargine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ganlee Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ganlee Product Profiles, Application and Specification
-
Table Ganlee Insulin Glargine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
